Literature DB >> 2761879

Antibiotic therapy costs.

H C Atkinson1, S T Chambers, A M McGinlay.   

Abstract

The total cost of antibiotics, rather than acquisition costs alone was estimated. Preparation and administration costs, laboratory and monitoring costs, and labour costs are considered separately for the major antibiotics used within Christchurch Hospital. The oral route of antibiotic administration is by far the cheapest. The cost of infusion therapy compared with an IV push is considerable. This added about +15-+30 in equipment costs and another +20-+30 in labour costs and often constituted over 50% of the total cost of therapy. The cost of adverse reactions and differences in efficacy should ultimately be included but it was impossible to quantitate these factors in terms of absolute costs. Acquisition costs alone are a poor guide to the true costs of therapy. The cost of administering the drug should be considered in the contexts of efficacy, toxicity and impact on the environment. We contend that these considerations should be implied to the overall impact on the hospital budget, rather than the pharmacy costs alone.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2761879

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  5 in total

Review 1.  Treatment of urinary tract infection. Clinical and economic considerations.

Authors:  R J Plumridge; C L Golledge
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

Review 2.  Clinical and economic considerations in the use of third-generation oral cephalosporins.

Authors:  S T Chambers; D R Murdoch; M J Pearce
Journal:  Pharmacoeconomics       Date:  1995-05       Impact factor: 4.981

3.  Using cost of infection as a tool to demonstrate a difference in prophylactic antibiotic efficacy: a prospective randomized comparison of the pharmacoeconomic effectiveness of ceftriaxone and cefotaxime prophylaxis in abdominal surgery.

Authors:  John C Woodfield; Andre M Van Rij; Ross A Pettigrew; Antje van der Linden; Donna Bolt
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

4.  Cost-effectiveness comparison of cefepime and ceftazidime using decision analysis.

Authors:  J A Paladino
Journal:  Pharmacoeconomics       Date:  1994-06       Impact factor: 4.981

5.  Cost comparison of antibacterial therapies for serious infections. A New Zealand 3-hospital study.

Authors:  W G Scott; H M Scott; S Henderson; A Inder; J Sanders; R Spearing; C McArthur; J Judson; B Baker; P Hicks; P Cotterell
Journal:  Pharmacoeconomics       Date:  1999-08       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.